Sinopharm Group Co. Ltd. (HKG:1099)
18.72
+0.01 (0.05%)
Oct 21, 2025, 11:59 AM HKT
Sinopharm Group Market Cap
Sinopharm Group has a market cap or net worth of 58.39 billion as of October 20, 2025. Its market cap has increased by 2.80% in one year.
Market Cap
58.39B
Enterprise Value
162.74B
Revenue
630.98B
Ranking
n/a
PE Ratio
7.80
Stock Price
18.72
Market Cap Chart
Since September 23, 2009, Sinopharm Group's market cap has increased from 40.42B to 58.39B, an increase of 44.44%. That is a compound annual growth rate of 2.31%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 17, 2025 | 57.48B | -13.52% |
Dec 31, 2024 | 66.47B | 4.16% |
Dec 29, 2023 | 63.82B | 3.07% |
Dec 30, 2022 | 61.91B | 16.98% |
Dec 31, 2021 | 52.93B | -10.07% |
Dec 31, 2020 | 58.86B | -30.29% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeOne Medicines AG | 270.59B |
Hansoh Pharmaceutical Group Company | 220.97B |
JD Health International | 194.49B |
Innovent Biologics | 148.75B |
WuXi Biologics | 142.91B |
Sino Biopharmaceutical | 130.14B |
Akeso | 112.93B |
Sichuan Kelun-Biotech Biopharmaceutical | 106.89B |